Log In Get Started
Press Releases May 28, 2026 04:05 PM

Equillium to Participate in the 2026 Jefferies Global Healthcare Conference

Equillium to present at 2026 Jefferies Global Healthcare Conference

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
EQ

Equillium, Inc., a biotech company focused on therapies for autoimmune and inflammatory disorders, announced its management team will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference, providing an opportunity to engage with investors.

Equillium to Participate in the 2026 Jefferies Global Healthcare Conference
EQ
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Equillium management to participate in a fireside chat at a major healthcare conference.
  • Opportunity to meet and engage with investors attending the conference.
  • Company focuses on developing novel therapies for severe autoimmune and inflammatory diseases.

LA JOLLA, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 4:55pm EDT.

Members of the Equillium management team will be available to meet with investors who are registered to attend the conference.

About Equillium
Equillium is a biotechnology innovator with a mission to develop highly impactful therapies to treat severe autoimmune and inflammatory disorders.

For more information, visit www.equilliumbio.com.

Investor Contact 
PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
[email protected]


Risks

  • No specific new product or clinical data announced, reliance on future developments for growth.
  • Market and investor reception depends on progress in clinical trials and regulatory approvals.
  • Biotechnology sector risks including clinical trial failures, regulatory hurdles, and competitive landscape.

More from Press Releases

Trump Media Settles Legal Disputes Jul 19, 2026 GEnx-1B Engines Surpass 50 Million Flight Hours Jul 19, 2026 XA Investments President Kimbery Flynn Speaks to Shareholders About XFLT Proxy Vote Jul 19, 2026 4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population Jul 18, 2026 UFC Names Meridian Holdings Official Sponsor of Fight Night Belgrade Jul 18, 2026